AdaptHealth Corp (NASDAQ: AHCO) on Friday, soared 3.57% from the previous trading day, before settling in for the closing price of $10.09. Within the past 52 weeks, AHCO’s price has moved between $6.37 and $12.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 62.79%. The company achieved an average annual earnings per share of -37.76%. With a float of $82.77 million, this company’s outstanding shares have now reached $132.63 million.
The extent of productivity of a business whose workforce counts for 10700 workers is very important to gauge. In terms of profitability, gross margin is 14.72%, operating margin of -7.46%, and the pretax margin is -22.26%.
AdaptHealth Corp (AHCO) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of AdaptHealth Corp is 38.45%, while institutional ownership is 60.36%. The most recent insider transaction that took place on Aug 19 ’24, was worth 107,058. Before that another transaction happened on Aug 15 ’24, when Company’s Former Affiliate proposed sale 25,614 for $10.04, making the entire transaction worth $257,165.
AdaptHealth Corp (AHCO) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -3.43 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.19) by -3.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -37.76% per share during the next fiscal year.
AdaptHealth Corp (NASDAQ: AHCO) Trading Performance Indicators
AdaptHealth Corp (AHCO) is currently performing well based on its current performance indicators. A quick ratio of 0.94 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.43. Likewise, its price to free cash flow for the trailing twelve months is 8.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.17, a number that is poised to hit 0.18 in the next quarter and is forecasted to reach 1.11 in one year’s time.
Technical Analysis of AdaptHealth Corp (AHCO)
The latest stats from [AdaptHealth Corp, AHCO] show that its last 5-days average volume of 0.88 million was inferior to 1.07 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 56.38%. Additionally, its Average True Range was 0.53.
During the past 100 days, AdaptHealth Corp’s (AHCO) raw stochastic average was set at 56.39%, which indicates a significant decrease from 79.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 111.55% in the past 14 days, which was higher than the 61.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.44, while its 200-day Moving Average is $9.29. Now, the first resistance to watch is $10.71. This is followed by the second major resistance level at $10.97. The third major resistance level sits at $11.30. If the price goes on to break the first support level at $10.12, it is likely to go to the next support level at $9.79. Assuming the price breaks the second support level, the third support level stands at $9.53.
AdaptHealth Corp (NASDAQ: AHCO) Key Stats
Market capitalization of the company is 1.41 billion based on 133,202K outstanding shares. Right now, sales total 3,200 M and income totals -678,900 K. The company made 805,980 K in profit during its latest quarter, and 19,440 K in sales during its previous quarter.
